HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seyyed Mehdi Jafari Selected Research

N-(3-pyridylmethyl)adriamycin (YM 1)

1/2023Anti-cancer effect of entacaponeon esophageal cancer cells via apoptosis induction and cell cycle modulation.
1/2023A1 adenosine receptor antagonist induces cell apoptosis in KYSE-30 and YM-1 esophageal cancer cell lines.
8/2022Decreased Expression of LAMB3 Is Associated with Esophageal Cancer Stem Cell Formation.
2/2021Knockdown of TAZ decrease the cancer stem properties of ESCC cell line YM-1 by modulation of Nanog, OCT-4 and SOX2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seyyed Mehdi Jafari Research Topics

Disease

16Neoplasms (Cancer)
03/2024 - 02/2015
6Breast Neoplasms (Breast Cancer)
03/2024 - 02/2015
4Esophageal Neoplasms (Esophageal Cancer)
07/2023 - 08/2022
3Esophageal Squamous Cell Carcinoma
12/2022 - 08/2022
3Ovarian Neoplasms (Ovarian Cancer)
12/2018 - 01/2017
2Neoplasm Metastasis (Metastasis)
03/2024 - 08/2022
2Inflammation (Inflammations)
08/2023 - 07/2023
2Lung Neoplasms (Lung Cancer)
06/2023 - 01/2023
1Insulin Resistance
08/2023
1Hepatocellular Carcinoma (Hepatoma)
06/2023
1Colonic Neoplasms (Colon Cancer)
06/2023
1Parkinson Disease (Parkinson's Disease)
01/2023
1Carcinogenesis
08/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2017
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016

Drug/Important Bio-Agent (IBA)

5Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2024 - 01/2017
4N-(3-pyridylmethyl)adriamycin (YM 1)IBA
01/2023 - 02/2021
2MicroRNAs (MicroRNA)IBA
08/2023 - 12/2022
2EnzymesIBA
06/2023 - 01/2023
2Protein Isoforms (Isoforms)IBA
06/2023 - 01/2023
2Proteins (Proteins, Gene)FDA Link
06/2023 - 08/2022
2Caspase 3 (Caspase-3)IBA
01/2023 - 12/2018
2Messenger RNA (mRNA)IBA
01/2023 - 08/2022
2Cyclin D1IBA
10/2019 - 01/2017
2SesquiterpenesIBA
10/2019 - 02/2015
2LactonesIBA
10/2019 - 02/2015
1Insulin (Novolin)FDA Link
08/2023
1Small Untranslated RNAIBA
08/2023
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2023
1Interleukin-6 (Interleukin 6)IBA
08/2023
1FibrillinsIBA
07/2023
1SeleniumIBA
07/2023
1NucleotidesIBA
06/2023
1entacapone (Comtan)FDA Link
01/2023
1Purinergic P1 Receptor AntagonistsIBA
01/2023
16-methyladenineIBA
01/2023
1TransferasesIBA
01/2023
1Purine NucleosidesIBA
01/2023
1catechol (pyrocatechol)IBA
01/2023
1Adenosine (Adenocard)FDA LinkGeneric
01/2023
1Adenosine A1 ReceptorIBA
01/2023
1GTP-Binding Proteins (G-Protein)IBA
01/2023
1N-methyladenosineIBA
01/2023
1Long Noncoding RNAIBA
11/2022
1taxaneIBA
08/2022
1Docetaxel (Taxotere)FDA Link
08/2022
1Protein Kinases (Protein Kinase)IBA
08/2022
1BromidesIBA
10/2019
1Caspase 6IBA
12/2018
1LectinsIBA
12/2018
1CaspasesIBA
02/2018
1lathyraneIBA
10/2017
1DiterpenesIBA
10/2017
1artenimol (dihydroartemisinin)IBA
01/2017
1Cytochromes c (Cytochrome c)IBA
01/2017
1Cyclin-Dependent Kinase 4IBA
01/2017
1N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
01/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1AntioxidantsIBA
01/2016
1britanninIBA
02/2015

Therapy/Procedure

6Therapeutics
01/2023 - 02/2015
2Drug Therapy (Chemotherapy)
06/2023 - 08/2022
1Traditional Medicine (Folk Remedies)
10/2017